摘要
目的:观察胸膜腔内灌注香菇多糖治疗恶性胸腔积液的疗效及不良反应。方法:回顾性分析本院使用胸膜腔内灌注香菇多糖治疗恶性胸腔积液患者35例,其中肺癌26例,胸膜间皮瘤3例,乳腺癌3例,非何杰金氏淋巴瘤2例,胰腺癌1例。结果:完全缓解(CR)12例、部分缓解(PH)14例、无效(NC)7例、进展(PD0)2例。总有效率为74.29%。8例出现不同程度的发热,温度37-38℃,1例出现一过性高热(39.3℃);6例患者出现不同程度的胸痛和胸部不适,一般不需特殊处置;2例出现恶心、呕吐。未发现对肝肾功能的损害、骨髓抑制及脱发等其他不良反应。结论:香菇多糖是一种有效的免疫调节药物,胸膜腔内灌注可用来治疗恶性胸腔积液,有效改善患者的生存质量,无明显的不良反应,应用方便安全,疗效肯定,易被患者接受,值得推广使用。
Object: To observe the curative effect and the side effects of lentinan(LNT) when injection in pleural cavity to treat malig- nant plural effusion. Methods: Thirty - five patients with malignant pleural effusion were treated with intracavitary injection of LNT. Among them, 26 cases were lung carcinoma, 3 were mesothelioma, 3 were breast carcinoma, 2 were leucoma and 1 pancreatic cancer. 4 mg of LNT were injected into the pleural cavity through a fine tube. Results: Among all, 12 cases achieved complete remission (CR), 14 got partial remission (PR), 7 got no change (NC) and 2 got progressive disease (PD). The total effective rate was 74.29% (CR+ PR% ). Main side effects were fever (8cases), pectoralgia(6 cases), nausea and omitting (2 cases). Nobody showed severe side - effects need to treated specially. Conclusion: Lentinan is a new and effective anti tumor drug and can be safely used to treat malignant pleural effusion.
出处
《天津药学》
2006年第2期35-37,共3页
Tianjin Pharmacy
关键词
香菇多糖
胸腔积液
胸腔内注射
lentinan, pleural effusion, intracavitary injection